sglt2 and glp 1 together GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Illustration of potential synergistic effects

Even in India, early access to innovator brands like Novo Nordisk Ozempic and Wegovy (both semaglutide), plus Rybelsus, Victoza, and Trulicity, meant bills of 10,00020,000 per month for many patients, putting these drugs out of reach for the average middle-class household

Last reviewed: May 2026.

When accompanied by metabolic disorders, such as IR and dyslipidaemia, it can lead to hyperlipidaemia, hypertension, metabolic syndrome and diabetes

[2] Medvi Review After 10 Months of Use Better Than I Expected

These effects tend to be transient and lessen over time

The overwhelming majority of employers cover at least some GLP-1 medications for diabetes